AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks Does KORU KRMD stock offer a good entry point KORU posts 505 EPS beat tops consensus forecasts Vanguard SP 500 ETF VOO 3 Peer Vanguard Index Funds Positioned to Outperform the SP 500 Over the 5Year Forward Horizon Who are Badger Meter BMI top shareholders Bearish Sentiment 20260427 Is Collegium COLL stock showing downside risk Q4 2025 Earnings Fall Short